<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03582917</url>
  </required_header>
  <id_info>
    <org_study_id>UIoannina</org_study_id>
    <nct_id>NCT03582917</nct_id>
  </id_info>
  <brief_title>The Role of VitD in Rehabilitation of Idiopathic Adolescent Scoliosis</brief_title>
  <acronym>ScoliVit</acronym>
  <official_title>The Role of VitD in Rehabilitation of Idiopathic Adolescent Scoliosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ioannina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ioannina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this current prospective study is to determine the role of vitamin D in the
      development and restoration of spinal deformities in adolescence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigator will record the medical history of each patient and information such as age,
      body size (weight, height) and body mass index (BMI = kg / m ^ 2). Girls will also be given
      the time of appearance of menstruation, a factor that needs to be evaluated because the
      growth of the skeleton continues three years after its appearance. Patients will be subjected
      to Adam's Test, x-ray's and as well as lateral bending radiographs.In the first contact with
      each patient, will be evaluated bone density measured by DEXA as well as haematological
      testing including PTH, alkaline phosphatase (ALP), calcium (Ca), phosphorus( P ), Calcitonin
      and, of course, vitamin D (total and metabolite 25 (OH) D).

      Each patient's follow-up will be completed in two years by a clinical examination every six
      months and a clinical, laboratory and radiological examination per year. Patients will be
      divided into two groups. In a group with patients with normal 25 (OH) D and in a second group
      with patients with low levels of 25 (OH) D. Members of the second group will receive
      substitution treatment with an appropriate formulation. The results will be collected and
      evaluated using statistical programme.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 20, 2018</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>25(OH)D</measure>
    <time_frame>48 weeks</time_frame>
    <description>Measurement of the major metabolite of vitamin D</description>
  </primary_outcome>
  <primary_outcome>
    <measure>X - rays</measure>
    <time_frame>48 weeks</time_frame>
    <description>Cobb angle measurement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dexa</measure>
    <time_frame>48 weeks</time_frame>
    <description>BMD and Z - score measurement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>BMD (weight in kilograms, height in meters)</measure>
    <time_frame>48 weeks</time_frame>
    <description>weight and height will be combined to report BMI in kg/m^2</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Scoliosis; Adolescence</condition>
  <arm_group>
    <arm_group_label>Alphacalscidol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0,5mg tablet by mouth, one each day for one year</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alphacalcidol</intervention_name>
    <description>Alphacalcidol 0,5mg tablet</description>
    <arm_group_label>Alphacalscidol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Idiopathic Adolescent Scoliosis

          -  Risser sign &lt;3-4

        Exclusion Criteria:

          -  Neuromuscular diseases

          -  metabolic disease

          -  Liver, lung, thyroid and parathyroid gland disorders.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Patients will be boys aged 10 to 18 and girls 10 to 16</gender_description>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lazaros Tagkalidis</last_name>
    <phone>+30 6977252028</phone>
    <email>akissdoc@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Avraam Ploumis, Ass. Professor</last_name>
    <phone>6932080701</phone>
    <email>aploumis@uoi.gr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Papanikolaou General Hospital</name>
      <address>
        <city>Asvestochori</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lazaros TagKalidis, MD</last_name>
      <phone>+30 6977252028</phone>
      <email>akissdoc@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Physical Medicine and Rehabilitation, University Hospital of Ioannina</name>
      <address>
        <city>Ioannina</city>
        <zip>45100</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Avraam Ploumis</last_name>
      <phone>6932080701</phone>
      <email>aploumis@uoi.gr</email>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>May 29, 2018</study_first_submitted>
  <study_first_submitted_qc>July 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2018</study_first_posted>
  <last_update_submitted>November 20, 2018</last_update_submitted>
  <last_update_submitted_qc>November 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ioannina</investigator_affiliation>
    <investigator_full_name>Avraam Ploumis</investigator_full_name>
    <investigator_title>Assistant Professor of PMR, Orthopaedic Spine Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scoliosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alfacalcidol</mesh_term>
    <mesh_term>Hydroxycholecalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

